Publicaciones en colaboración con investigadores/as de University of Manchester (19)

2023

  1. Author Correction: Pan-cancer analysis of whole genomes (Nature, (2020), 578, 7793, (82-93), 10.1038/s41586-020-1969-6)

    Nature

2022

  1. Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns (Nature Communications, (2020), 11, 1, (728), 10.1038/s41467-019-13825-8)

    Nature Communications

  2. Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower (Nature Communications, (2020), 11, 1, (734), 10.1038/s41467-019-13929-1)

    Nature Communications

  3. Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours (Nature Communications, (2020), 11, 1, (737), 10.1038/s41467-019-14052-x)

    Nature Communications

  4. Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer (Nature Communications, (2020), 11, 1, (733), 10.1038/s41467-019-13824-9)

    Nature Communications

  5. Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations (Nature Communications, (2020), 11, 1, (736), 10.1038/s41467-019-13885-w)

    Nature Communications

  6. Author Correction: Inferring structural variant cancer cell fraction (Nature Communications, (2020), 11, 1, (730), 10.1038/s41467-020-14351-8)

    Nature Communications

  7. Author Correction: Integrative pathway enrichment analysis of multivariate omics data (Nature Communications, (2020), 11, 1, (735), 10.1038/s41467-019-13983-9)

    Nature Communications

  8. Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes (Nature Communications, (2020), 11, 1, (729), 10.1038/s41467-020-14367-0)

    Nature Communications

  9. Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig (Nature Communications, (2020), 11, 1, (731), 10.1038/s41467-020-14352-7)

    Nature Communications

2021

  1. Subclone eradication analysis identifies targets for enhanced cancer therapy and reveals L1 retrotransposition as a dynamic source of cancer heterogeneity

    Cancer Research, Vol. 81, Núm. 19, pp. 4901-4909

2020

  1. Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (Nature Communications, (2020), 11, 1, (4748), 10.1038/s41467-020-18151-y)

    Nature Communications

  2. Pan-cancer analysis of whole genomes

    Nature, Vol. 578, Núm. 7793, pp. 82-93

  3. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

    Nature Communications, Vol. 11, Núm. 1

  4. Sex differences in oncogenic mutational processes

    Nature Communications, Vol. 11, Núm. 1

2017

  1. Sequential Exposure to Obesogenic Factors in Females Rats: From Physiological Changes to Lipid Metabolism in Liver and Mesenteric Adipose Tissue

    Scientific Reports, Vol. 7

2016

  1. Genomic insights into the Ixodes scapularis tick vector of Lyme disease

    Nature Communications, Vol. 7

2015

  1. Highly evolvable malaria vectors: The genomes of 16 Anopheles mosquitoes

    Science, Vol. 347, Núm. 6217

2014

  1. Phase II trial of cetuximab and conformal radiotherapy only in locally advanced pancreatic cancer with concurrent tissue sampling feasibility study

    Translational Oncology, Vol. 7, Núm. 1, pp. 55-64